Atzler, M.; Baudrexler, T.; Amberger, D.C.; Rogers, N.; Rabe, A.; Schmohl, J.; Wang, R.; Rank, A.; Schutti, O.; Hirschbühl, K.;
et al. In Vivo Induction of Leukemia-Specific Adaptive and Innate Immune Cells by Treatment of AML-Diseased Rats and Therapy-Refractory AML Patients with Blast Modulating Response Modifiers. Int. J. Mol. Sci. 2024, 25, 13469.
https://doi.org/10.3390/ijms252413469
AMA Style
Atzler M, Baudrexler T, Amberger DC, Rogers N, Rabe A, Schmohl J, Wang R, Rank A, Schutti O, Hirschbühl K,
et al. In Vivo Induction of Leukemia-Specific Adaptive and Innate Immune Cells by Treatment of AML-Diseased Rats and Therapy-Refractory AML Patients with Blast Modulating Response Modifiers. International Journal of Molecular Sciences. 2024; 25(24):13469.
https://doi.org/10.3390/ijms252413469
Chicago/Turabian Style
Atzler, Michael, Tobias Baudrexler, Daniel Christoph Amberger, Nicole Rogers, Alexander Rabe, Joerg Schmohl, Ruixiao Wang, Andreas Rank, Olga Schutti, Klaus Hirschbühl,
and et al. 2024. "In Vivo Induction of Leukemia-Specific Adaptive and Innate Immune Cells by Treatment of AML-Diseased Rats and Therapy-Refractory AML Patients with Blast Modulating Response Modifiers" International Journal of Molecular Sciences 25, no. 24: 13469.
https://doi.org/10.3390/ijms252413469
APA Style
Atzler, M., Baudrexler, T., Amberger, D. C., Rogers, N., Rabe, A., Schmohl, J., Wang, R., Rank, A., Schutti, O., Hirschbühl, K., Inngjerdingen, M., Deen, D., Eiz-Vesper, B., Schmid, C., & Schmetzer, H. M.
(2024). In Vivo Induction of Leukemia-Specific Adaptive and Innate Immune Cells by Treatment of AML-Diseased Rats and Therapy-Refractory AML Patients with Blast Modulating Response Modifiers. International Journal of Molecular Sciences, 25(24), 13469.
https://doi.org/10.3390/ijms252413469
